PTPRC and neoplasm: Figure 4B shows no significant increase in CD8/PD-1 double-positive cells from the CD45 positive tumor fraction, indicating that Aza-treated KPT277 cells do not induce PD-1 expression in tumor-associated CD8 T cells.